Oriental Rise Receives Nasdaq Staff Delisting Determination
Rhea-AI Summary
Oriental Rise (NASDAQ: ORIS) received a Nasdaq staff determination on April 15, 2026 to delist its ordinary shares for failing to maintain a minimum $1.00 bid price for 30 consecutive business days. The company plans to request a Nasdaq Hearings Panel hearing by April 22, 2026.
Because of a 1-for-20 reverse split on December 30, 2025, the company is ineligible for the 180-day cure period; a hearing request will stay suspension pending the Panel’s decision, but regaining compliance is not assured.
Positive
- Company will request a Nasdaq Hearings Panel hearing by April 22, 2026
- Filing a hearing request will stay trading suspension and Form 25-NSE filing pending Panel decision
- Company intends to present a plan to regain Nasdaq continued-listing compliance
Negative
- Nasdaq determined ORIS closed below $1.00 for 30 consecutive business days
- 1-for-20 reverse split on December 30, 2025 disqualified company from 180-day cure period
- If hearing fails, trading suspension effective April 24, 2026 and Nasdaq will file Form 25-NSE for removal
News Market Reaction – ORIS
On the day this news was published, ORIS declined 19.86%, reflecting a significant negative market reaction. Argus tracked a trough of -12.0% from its starting point during tracking. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $777K from the company's valuation, bringing the market cap to $3.13M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peer moves are mixed: RKDA up 4.04%, FAMI down 1.57%, while other listed peers show minimal or no change. With ORIS’s move direction unspecified and only one peer moving up and one down, trading appears stock-specific rather than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 09 | Renewable partnership | Positive | -23.9% | Agro-photovoltaic partnership framework targeting 50 MW and RMB165M investment. |
| Jan 15 | Listing compliance | Positive | +21.1% | Regained compliance with Nasdaq minimum bid price rule 5550(a)(2). |
| Jan 09 | Brand acquisition LOI | Positive | +13.4% | LOI to acquire PoDu white tea RTD brand and related assets. |
| Dec 30 | Tea group acquisition LOI | Positive | +22.1% | LOI for controlling stake in Hubei Daguan Tea Industry Group. |
Recent positive strategic and listing-related news mostly saw positive price reactions, with one notable divergence where a renewable partnership update coincided with a sharp decline.
Over the last several months, Oriental Rise reported multiple strategic steps, including non-binding LOIs to acquire PoDu’s white tea beverage brand (Jan 9, 2026) and Hubei Daguan Tea Industry Group (Dec 30, 2025). A key milestone was regaining compliance with Nasdaq’s minimum bid price rule on Jan 14, 2026, which drew a positive price response. However, a 50 MW agro-photovoltaic partnership update on Mar 9, 2026 coincided with a large selloff, indicating investor skepticism toward some growth initiatives.
Market Pulse Summary
The stock dropped -19.9% in the session following this news. A negative reaction despite earlier positive strategic announcements fits a pattern where investors remained cautious, as seen after the agro-photovoltaic partnership news that coincided with a 23.87% decline. The latest staff determination regarding delisting risk adds further pressure. Past reliance on corporate actions like reverse splits and capital structure changes highlights ongoing listing vulnerability that could amplify downside moves.
Key Terms
reverse stock split financial
form 25-nse regulatory
nasdaq hearings panel regulatory
minimum bid price regulatory
AI-generated analysis. Not financial advice.
NINGDE, China, April 20, 2026 (GLOBE NEWSWIRE) -- Oriental Rise Holdings Limited (NASDAQ: ORIS) (“Oriental Rise” or the “Company”), an integrated tea supplier in mainland China, today announced that it received a staff determination letter (the “Determination Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on April 15, 2026, notifying the Company that Nasdaq has determined to delist the Company’s ordinary shares from The Nasdaq Capital Market.
According to the Determination Letter, Nasdaq determined that the closing bid price of the Company’s listed securities had been below
Nasdaq further stated that, because the Company effected a 1-for-20 reverse stock split on December 30, 2025, the Company is not eligible for the 180-calendar day compliance period that would otherwise be available under Nasdaq Listing Rule 5810(c)(3)(A).
Nasdaq has advised the Company that, unless the Company requests a hearing before a Nasdaq Hearings Panel by April 22, 2026, trading in the Company’s ordinary shares will be suspended at the opening of business on April 24, 2026, and Nasdaq will file a Form 25-NSE with the U.S. Securities and Exchange Commission to remove the Company’s securities from listing and registration on The Nasdaq Stock Market.
The Company intends to timely request a hearing before the Nasdaq Hearings Panel. The hearing request will stay the suspension of the Company’s securities and the filing of the Form 25-NSE pending the Panel’s decision. The Company is currently evaluating its options and intends to present a plan to regain compliance with Nasdaq’s continued listing requirements.
There can be no assurance that the Hearings Panel will grant the Company’s request for continued listing or that the Company will be able to regain compliance with the applicable continued listing requirements.
About Oriental Rise Holdings Limited (NASDAQ: ORIS)
Oriental Rise Holdings Limited is an integrated supplier of tea products in mainland China. Its major tea products include primarily-processed tea consisting of white tea and black tea, as well as refined white tea and black tea. The Company’s business operations are vertically integrated, covering tea cultivation, processing of tea leaves, and the sale of tea products to tea business operators, such as wholesale distributors, and end-user retail customers in mainland China. The Company operates tea gardens located in Zherong County, Ningde City in Fujian Province of mainland China.
Forward-Looking Statements
Certain statements in this announcement are forward-looking statements, including, without limitation, statements regarding the Company’s intent to request a hearing before the Nasdaq Hearings Panel, its plans to regain compliance with Nasdaq’s continued listing requirements, and the outcome of any hearing process. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs. Words such as “believes,” “expects,” “intends,” “plans,” “may,” “will,” and similar expressions are intended to identify forward-looking statements.
The Company undertakes no obligation to update or revise any forward-looking statements, except as required by applicable law. Investors are cautioned that actual results may differ materially from those described in the forward-looking statements.
For investor and media inquiries, please contact:
Oriental Rise Holdings Limited
Investor Relations Department
Email: ir@mdhtea.cn
